CyberKnife Treatment for Adenocarcinoma

Adenocarcinoma is a cancer that forms in the mucus-secreting glands of the lungs and occurs most often in former or current smokers. Categorized as non-small cell lung cancer, the American Cancer Society estimates about 40 percent of lung cancers are adenocarcinomas.

CyberKnife Center of Chicago treats adenocarcinoma with stereotactic body radiation therapy using CyberKnife® technology. CyberKnife treatment is non-surgical and completed in five or fewer treatments. Adenocarcinomas are treated with precisely targeted, high-dose radiation while radiation exposure to healthy tissue surrounding the tumor is minimized. Tumors in the lung often move during a course of treatment as a patient breathes, but the CyberKnife’s advanced tracking system accounts for tumor movement and adjusts in real-time.

Patients can return to their normal activities immediately following treatment. Side effects if any, may include fatigue occurring early during or after treatment, and are typically gone within a few weeks. Late side effects can occur months or years later; some may require intervention. Discuss your specific case with your physician/s to fully understand the potential risks associated with your treatment regimen

If you’re interested in learning more about lung cancer treatment with CyberKnife, contact our center at 331-221-2050. You can also check out our lung cancer blog series for additional information and resources.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.